Schedule 13G ownership disclosure

TRANSLATE BIO INC

Security class unavailable · CUSIP: 89374L104

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,922,008
Percent of class
8.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-006502
Form type
SC 13G
Filer
Atlas Venture Fund VIII, L.P.
CIK
CIK 1451626
Filed
Feb 08, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub